Highlife Sas
Clinical trials sponsored by Highlife Sas, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart valve fix without cutting chest shows promise for High-Risk patients Results expected Dec 2026 (estimated)
-
New heart valve fix without open surgery under Real-World watch
Disease control Not yet recruitingThis registry will follow 150 people with severe mitral regurgitation who receive the HighLife transcatheter mitral valve replacement system. The goal is to see how well the device works and how safe it is when used in everyday medical practice. Participants are treated according…
Sponsor: HighLife SAS • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New heart valve device offers hope for patients too sick for surgery
Disease control Not yet recruitingThis study tests a new device called the HighLife TSMVR system for people with severe mitral regurgitation, a condition where the heart's mitral valve leaks. The device is placed through a catheter via a vein, avoiding open-heart surgery. The trial will include 240 participants w…
Sponsor: HighLife SAS • Aim: Disease control
Last updated Jun 26, 2026 17:26 UTC